With the study adding to a mix of conflicting trial results, it’s not yet time to update guidelines, Shyam Prabhakaran says.
Alteplase, a “clot-buster” medication used to treat ischemic stroke, acute myocardial infarctions, and acute pulmonary ...
Results from the CHOICE-2 trial show a 15% absolute increase in excellent functional outcomes with intra-arterial alteplase ...
News Medical on MSN
Post-thrombectomy alteplase linked to better stroke outcomes
Giving the clot-busting medication alteplase at the site of a blocked brain artery after blood clot removal may increase the ...
Delivering intra-arterial alteplase after successful mechanical thrombectomy improved functional recovery in patients with ...
This “long overdue” update expands the pools of patients eligible for thrombolysis and thrombectomy, and tackles pediatric ...
AIM: The “2026 Guideline for the Early Management of Patients With AIS” replaces the “2018 Guidelines for the Early Management of Patients With AIS” and the 2019 update to reflect recent advances in ...
Penumbra (NYSE:PEN) announced today that it launched the Lightning Flash 3.0 computer-assisted vacuum thrombectomy (CAVT) ...
SonoVascular announced today that it has completed the first close of its $6 million Series A financing round.
In patients with acute stroke and a large infarct of unrestricted size, thrombectomy and medical care led to better functional outcomes and lower mortality compared with medical care alone, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results